STOCK TITAN

Nature’s Sunshine (NASDAQ: NATR) CFO exits as Jonathan Lanoy named interim finance chief

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Nature’s Sunshine Products, Inc. reported that Chief Financial Officer L. Shane Jones has resigned effective June 5, 2026, and stated that his decision was not due to any disagreement over the company’s financial reporting or accounting practices. On May 8, 2026, the company appointed longtime finance executive Jonathan D. Lanoy as Interim Principal Financial Officer. Lanoy currently serves as Senior Vice President, Chief Accounting Officer, and Principal Accounting Officer and has been with the company’s finance organization since 2008. Under an existing employment agreement, he receives an annual base salary of $301,551, a target annual bonus equal to 50 percent of base salary, and may receive 12 months of salary and health coverage continuation if his employment ends under specified conditions.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Base salary $301,551 per year Annual base salary for Jonathan D. Lanoy under Employment Agreement
Target bonus 50% of base salary Target annual bonus percentage for Jonathan D. Lanoy
Severance duration 12 months Monthly severance payments of one‑twelfth base salary if eligible
COBRA reimbursement period 12 months Reimbursement for continued health insurance coverage under COBRA
Lanoy age 51 years Age of Interim Principal Financial Officer Jonathan D. Lanoy
Principal Financial Officer financial
"Mr. Jonathan D. Lanoy was appointed to serve as the Company’s Interim Principal Financial Officer."
The principal financial officer is the senior executive who runs a company's financial operations: preparing and certifying financial reports, managing accounting controls, budgets and cash flow, and advising on financial strategy. Investors care about this role because its competence affects how trustworthy the company’s numbers are, how well it manages risk and capital needs, and the credibility of forecasts—like the chief navigator steering a firm's financial course.
Chief Accounting Officer financial
"Mr. Lanoy, 51, currently serves as the Company’s Senior Vice President, Chief Accounting Officer, and Principal Accounting Officer"
A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.
Employment Agreement financial
"Mr. Lanoy and the Company previously entered into an employment agreement (the “Employment Agreement”)"
Cause financial
"if his employment is terminated by the Company without Cause, if he resigns with Good Reason"
Good Reason financial
"if his employment is terminated by the Company without Cause, if he resigns with Good Reason"
COBRA financial
"reimbursement for the costs he incurs for continuation of his health insurance coverage under COBRA for a period of 12 months."
COBRA is a U.S. federal law that lets employees and their dependents temporarily keep employer-sponsored health insurance after job loss, reduction in hours, or other qualifying events by paying the premiums themselves. Investors should care because offering COBRA can affect a company’s cash flow, administrative costs and legal disclosures when workforce changes occur—similar to a former club member paying to keep their membership active after leaving the club.
0000275053false00002750532025-11-062025-11-0600002750532026-05-072026-05-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 11, 2026

 NS-logo-darkgreen.jpg
NATURE’S SUNSHINE PRODUCTS, INC.
(Exact name of registrant specified in its charter)
 
Utah 001-34483 87-0327982
(State or other jurisdiction of
incorporation)
 (Commission File Number) (I.R.S. Employer Identification No.)
 2901 West Bluegrass Blvd., Suite 100
Lehi, Utah 84043
(Address of principal executive offices and zip code)

Registrant’s telephone, including area code:  (801) 341-7900

N/A
(Former name and former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each ClassTrading SymbolName of each exchange on which registered
Common Stock, no par valueNATRNasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Chief Financial Officer

On May 8, 2026, L. Shane Jones notified Nature’s Sunshine Products, Inc. (the “Company”) that he is resigning as the Company’s Chief Financial Officer effective June 5, 2026. As the Company’s Chief Financial Officer, Mr. Jones also served as the Company’s Principal Financial Officer. Mr. Jones’ resignation was not the result of any disagreement with the Company on any matter relating to the Company’s financial reporting or accounting policies, procedures, estimates, or judgments.

Appointment of Principal Financial Officer

On May 8, 2026, Mr. Jonathan D. Lanoy was appointed to serve as the Company’s Interim Principal Financial Officer. Mr. Lanoy, 51, currently serves as the Company’s Senior Vice President, Chief Accounting Officer, and Principal Accounting Officer, positions in which he has served since January 24, 2023. Prior to that he served as the Company’s Vice President of Finance and Corporate Controller since February 2017, and in various other positions in the finance department of the Company since 2008. Before joining the Company, Mr. Lanoy was an assurance manager at the public accounting firm of Ernst & Young. Mr. Lanoy is a Certified Public Accountant and holds a Masters of Professional Accountancy and a Bachelor of Arts degree in Accounting from Weber State University.

Mr. Lanoy and the Company previously entered into an employment agreement (the “Employment Agreement”) pursuant to which Mr. Lanoy will receive an annual base salary of $301,551 and have a target annual bonus percentage of 50 percent of his base salary. The Employment Agreement also provides that Mr. Lanoy will receive the following benefits if his employment is terminated by the Company without Cause, if he resigns with Good Reason, or if his employment is terminated as a result of his death or Incapacity:

payment of all accrued and unpaid base salary through the date of his termination and reimbursement of any unreimbursed expenses (“Accrued Pay”);
monthly severance payments equal to one-twelfth of his annual base salary for a period of 12 months; and
reimbursement for the costs he incurs for continuation of his health insurance coverage under COBRA for a period of 12 months.

The terms Cause, Good Reason and Incapacity are defined in the Employment Agreement. The severance benefits described above, other than the Accrued Pay, are subject to Mr. Lanoy executing a release in favor of the Company and complying with the restrictive covenants set forth in the Employment Agreement, including a covenant not to compete with the Company for a period of 12 months following the termination of his employment with the Company.

The description of the terms and provisions of the Employment Agreement set forth above is qualified in its entirety by reference to the actual Employment Agreement, a copy of which is attached hereto as Exhibit 10.1, and incorporated herein by reference.

There is no arrangement or understanding between Mr. Lanoy and any other person pursuant to which he was selected as an officer of the Company. Mr. Lanoy has no family relationship (within the meaning of Item 401(d) of Regulation S-K) with any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer. There has been no transaction since the beginning of the Company’s last fiscal year, and there is no currently proposed transaction, in excess of $120,000 in which the Company is or was a participant and in which Mr. Lanoy or any of his immediate family members (within the meaning of Item 404 of Regulation S-K) had or will have a direct or indirect material interest.





Item 9.01    Financial Statements and Exhibits
Item No. Exhibit
10.1
Employment Agreement between the Company and Jonathan D. Lanoy.


104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 NATURE’S SUNSHINE PRODUCTS, INC.
   
Dated: May 11, 2026By:/s/ Nathan G. Brower
  Nathan G. Brower, Executive Vice President, General Counsel and Corporate Secretary

FAQ

Why did Nature’s Sunshine (NATR) CFO L. Shane Jones resign?

L. Shane Jones resigned as Chief Financial Officer effective June 5, 2026. The company stated his resignation was not due to any disagreement about financial reporting, accounting policies, procedures, estimates, or judgments, indicating an orderly leadership transition rather than a dispute-driven departure.

Who is replacing the CFO at Nature’s Sunshine (NATR)?

Nature’s Sunshine appointed Jonathan D. Lanoy as Interim Principal Financial Officer on May 8, 2026. Lanoy is currently Senior Vice President, Chief Accounting Officer, and Principal Accounting Officer and has served in various finance roles at the company since 2008, providing continuity.

What is Jonathan Lanoy’s compensation as an executive at NATR?

Jonathan Lanoy’s employment agreement provides an annual base salary of $301,551 and a target annual bonus of 50 percent of base salary. This structure aligns his pay with both fixed compensation and performance-based incentives, subject to the company’s applicable bonus plans and criteria.

What severance benefits can Jonathan Lanoy receive from Nature’s Sunshine?

If terminated without Cause, if he resigns for Good Reason, or upon death or Incapacity, Jonathan Lanoy is entitled to accrued salary, 12 months of monthly severance equal to one-twelfth of base salary, and reimbursement of COBRA health insurance costs for 12 months, subject to a release and covenants.

Are there any special arrangements behind Jonathan Lanoy’s appointment at NATR?

The filing states there is no arrangement or understanding between Jonathan Lanoy and any other person pursuant to which he was selected as an officer. It also notes he has no family relationships with directors or executive officers, supporting the independence of his appointment process.

Filing Exhibits & Attachments

4 documents